XML 87 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidating Guarantor Financial Information
3 Months Ended
Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidating Guarantor Financial Information
Consolidating Guarantor Financial Information:
The 2014 Senior Notes issued by Albemarle Corporation (the “Issuer”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Rockwood Holdings, Inc. (“RHI”) and Rockwood Specialties Group, Inc. (“RSGI”) (the “Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned subsidiaries of the Issuer. The guarantees are general senior unsecured obligations of the Guarantor Subsidiaries and rank equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantor Subsidiaries that are not, by their terms, otherwise expressly subordinated. The note guarantees will be released when the 4.625% senior notes assumed by Albemarle upon the acquisition of Rockwood are repaid or otherwise discharged.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among the Issuer, Guarantor Subsidiaries and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantor Subsidiaries to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Issuer, Guarantor Subsidiaries, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.
Condensed Consolidating Statement of Income
Three Months Ended March 31, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
378,172

 
$

 
$
687,615

 
$
(181,383
)
 
$
884,404

Cost of goods sold
258,124

 

 
546,776

 
(178,962
)
 
625,938

Gross profit
120,048

 

 
140,839

 
(2,421
)
 
258,466

Selling, general and administrative expenses
40,517

 

 
95,248

 

 
135,765

Research and development expenses
13,368

 

 
13,124

 

 
26,492

Acquisition and integration related costs
38,880

 

 
20,643

 

 
59,523

Intercompany service fee
5,665

 

 
(5,665
)
 

 

Operating profit
21,618

 

 
17,489

 
(2,421
)
 
36,686

Interest and financing expenses
(26,656
)
 
(10,771
)
 
1,681

 

 
(35,746
)
Intergroup interest and financing expenses
(5,914
)
 
9,061

 
(3,147
)
 

 

Other income (expenses), net
28,568

 
(50,052
)
 
71,441

 

 
49,957

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
17,616

 
(51,762
)
 
87,464

 
(2,421
)
 
50,897

Income tax expense (benefit)
10,892

 
(6,928
)
 
11,068

 
(892
)
 
14,140

Income (loss) from continuing operations before equity in net income of unconsolidated investments
6,724

 
(44,834
)
 
76,396

 
(1,529
)
 
36,757

Equity in net income of unconsolidated investments (net of tax)
2,019

 

 
8,373

 

 
10,392

Net income (loss) from continuing operations
8,743

 
(44,834
)
 
84,769

 
(1,529
)
 
47,149

Income (loss) from discontinued operations (net of tax)

 

 

 

 

Equity in undistributed earnings of subsidiaries
34,372

 
62,630

 
8,898

 
(105,900
)
 

Net income
43,115

 
17,796

 
93,667

 
(107,429
)
 
47,149

Net income attributable to noncontrolling interests

 

 
(4,034
)
 

 
(4,034
)
Net income attributable to Albemarle Corporation
$
43,115

 
$
17,796

 
$
89,633

 
$
(107,429
)
 
$
43,115



Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended March 31, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
43,115

 
$
17,796

 
$
93,667

 
$
(107,429
)
 
$
47,149

Total other comprehensive loss, net of tax
(299,869
)
 
(496,500
)
 
(635,434
)
 
1,131,834

 
(299,969
)
Comprehensive loss
(256,754
)
 
(478,704
)
 
(541,767
)
 
1,024,405

 
(252,820
)
Comprehensive income attributable to noncontrolling interests

 

 
(3,934
)
 

 
(3,934
)
Comprehensive loss attributable to Albemarle Corporation
$
(256,754
)
 
$
(478,704
)
 
$
(545,701
)
 
$
1,024,405

 
$
(256,754
)

Condensed Consolidating Statement of Income
Three Months Ended March 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
376,324

 
$

 
$
383,831

 
$
(160,312
)
 
$
599,843

Cost of goods sold
261,593

 

 
303,361

 
(160,710
)
 
404,244

Gross profit
114,731

 

 
80,470

 
398

 
195,599

Selling, general and administrative expenses
55,769

 

 
22,335

 

 
78,104

Research and development expenses
14,156

 

 
8,416

 

 
22,572

Restructuring and other charges, net
3,000

 

 
14,000

 

 
17,000

Intercompany service fee
5,070

 

 
(5,070
)
 

 

Operating profit
36,736

 

 
40,789

 
398

 
77,923

Interest and financing expenses
(8,798
)
 

 
25

 

 
(8,773
)
Other income, net
208

 

 
935

 

 
1,143

Income from continuing operations before income taxes and equity in net income of unconsolidated investments
28,146

 

 
41,749

 
398

 
70,293

Income tax expense
10,371

 

 
2,674

 
145

 
13,190

Income from continuing operations before equity in net income of unconsolidated investments
17,775

 

 
39,075

 
253

 
57,103

Equity in net income of unconsolidated investments (net of tax)
1,936

 

 
6,965

 

 
8,901

Net income from continuing operations
19,711

 

 
46,040

 
253

 
66,004

Loss from discontinued operations (net of tax)
(413
)
 

 
(1,356
)
 

 
(1,769
)
Equity in undistributed earnings of subsidiaries
37,285

 

 

 
(37,285
)
 

Net income
56,583

 

 
44,684

 
(37,032
)
 
64,235

Net income attributable to noncontrolling interests

 

 
(7,652
)
 

 
(7,652
)
Net income attributable to Albemarle Corporation
$
56,583

 
$

 
$
37,032

 
$
(37,032
)
 
$
56,583



Condensed Consolidating Statement of Comprehensive Income
Three Months Ended March 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
56,583

 
$

 
$
44,684

 
$
(37,032
)
 
$
64,235

Total other comprehensive loss, net of tax
(9,318
)
 

 
(5,262
)
 
5,045

 
(9,535
)
Comprehensive income
47,265

 

 
39,422

 
(31,987
)
 
54,700

Comprehensive income attributable to noncontrolling interests

 

 
(7,435
)
 

 
(7,435
)
Comprehensive income attributable to Albemarle Corporation
$
47,265

 
$

 
$
31,987

 
$
(31,987
)
 
$
47,265


Condensed Consolidating Balance Sheet
March 31, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
2,263

 
$
2,054

 
$
257,104

 
$

 
$
261,421

Trade accounts receivable, less allowance for doubtful accounts
105,835

 

 
521,130

 

 
626,965

Other accounts receivable
12,518

 
23,216

 
47,299

 

 
83,033

Intergroup receivable
56,069

 
49

 
40,953

 
(97,071
)
 

Inventories
201,563

 

 
431,877

 
(13,263
)
 
620,177

Other current assets
88,100

 

 
104,692

 
(97,845
)
 
94,947

Total current assets
466,348

 
25,319

 
1,403,055

 
(208,179
)
 
1,686,543

Property, plant and equipment, at cost
1,737,949

 

 
2,283,684

 

 
4,021,633

Less accumulated depreciation and amortization
1,060,877

 

 
343,729

 

 
1,404,606

Net property, plant and equipment
677,072

 

 
1,939,955

 

 
2,617,027

Investments
74,362

 
4,891

 
573,719

 

 
652,972

Investment in subsidiaries
6,963,998

 
11,104,115

 
6,368,690

 
(24,436,803
)
 

Other assets
28,247

 
12,319

 
152,245

 
(12,599
)
 
180,212

Goodwill
49,214

 

 
2,660,456

 

 
2,709,670

Other intangibles, net of amortization
20,282

 

 
1,928,053

 

 
1,948,335

Intergroup receivable

 
3,311,271

 
1,817,653

 
(5,128,924
)
 

Total assets
$
8,279,523

 
$
14,457,915

 
$
16,843,826

 
$
(29,786,505
)
 
$
9,794,759

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
119,879

 
$

 
$
220,936

 
$

 
$
340,815

Intergroup payable
40,939

 
36

 
56,096

 
(97,071
)
 

Accrued expenses
154,992

 
119,221

 
279,734

 

 
553,947

Current portion of long-term debt
461,767

 

 
10,042

 

 
471,809

Dividends payable
32,261

 

 

 

 
32,261

Income taxes payable

 
97,845

 
58,404

 
(98,737
)
 
57,512

Total current liabilities
809,838

 
217,102

 
625,212

 
(195,808
)
 
1,456,344

Long-term debt
2,218,848

 
1,291,442

 
31,022

 

 
3,541,312

Postretirement benefits
55,578

 

 

 
(280
)
 
55,298

Pension benefits
125,659

 

 
325,533

 

 
451,192

Intergroup payable
1,804,370

 
1,016,759

 
2,307,795

 
(5,128,924
)
 

Other noncurrent liabilities
52,263

 
58,970

 
130,738

 

 
241,971

Deferred income taxes
103,584

 

 
710,047

 
(12,319
)
 
801,312

Commitments and contingencies
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
1,122

 

 
6,808

 
(6,808
)
 
1,122

Additional paid-in capital
2,049,309

 
12,352,346

 
12,117,045

 
(24,469,391
)
 
2,049,309

Accumulated other comprehensive loss
(362,282
)
 
(496,500
)
 
(686,412
)
 
1,182,912

 
(362,282
)
Retained earnings
1,421,234

 
17,796

 
1,138,091

 
(1,155,887
)
 
1,421,234

Total Albemarle Corporation shareholders’ equity
3,109,383

 
11,873,642

 
12,575,532

 
(24,449,174
)
 
3,109,383

Noncontrolling interests

 

 
137,947

 

 
137,947

Total equity
3,109,383

 
11,873,642

 
12,713,479

 
(24,449,174
)
 
3,247,330

Total liabilities and equity
$
8,279,523

 
$
14,457,915

 
$
16,843,826

 
$
(29,786,505
)
 
$
9,794,759


Condensed Consolidating Balance Sheet
December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Trade accounts receivable, less allowance for doubtful accounts
91,849

 

 
293,363

 

 
385,212

Other accounts receivable
19,033

 

 
30,390

 

 
49,423

Intergroup receivable
74,102

 

 
18,097

 
(92,199
)
 

Inventories
201,006

 

 
171,543

 
(14,188
)
 
358,361

Other current assets
45,901

 

 
25,111

 
(4,926
)
 
66,086

Total current assets
2,362,693

 

 
1,097,470

 
(111,313
)
 
3,348,850

Property, plant and equipment, at cost
1,726,690

 

 
893,980

 

 
2,620,670

Less accumulated depreciation and amortization
1,047,372

 

 
341,430

 

 
1,388,802

Net property, plant and equipment
679,318

 

 
552,550

 

 
1,231,868

Investments
73,500

 

 
120,542

 

 
194,042

Investment in subsidiaries
1,551,071

 

 

 
(1,551,071
)
 

Other assets
35,837

 

 
125,119

 

 
160,956

Goodwill
49,212

 

 
194,050

 

 
243,262

Other intangibles, net of amortization
20,834

 

 
23,291

 

 
44,125

Total assets
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
122,479

 
$

 
$
109,226

 
$

 
$
231,705

Intergroup payable
18,097

 

 
74,102

 
(92,199
)
 

Accrued expenses
84,619

 

 
81,555

 

 
166,174

Current portion of long-term debt
692,280

 

 
18,816

 

 
711,096

Dividends payable
21,458

 

 

 

 
21,458

Income taxes payable
1,396

 

 
7,944

 
113

 
9,453

Total current liabilities
940,329

 

 
291,643

 
(92,086
)
 
1,139,886

Long-term debt
2,214,755

 

 
8,280

 

 
2,223,035

Postretirement benefits
56,424

 

 

 

 
56,424

Pension benefits
128,238

 

 
42,296

 

 
170,534

Other noncurrent liabilities
51,936

 

 
35,769

 

 
87,705

Deferred income taxes
21,318

 

 
35,566

 

 
56,884

Commitments and contingencies
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
780

 

 
6,808

 
(6,808
)
 
780

Additional paid-in capital
10,447

 

 
553,172

 
(553,172
)
 
10,447

Accumulated other comprehensive loss
(62,413
)
 

 
(51,073
)
 
51,073

 
(62,413
)
Retained earnings
1,410,651

 

 
1,061,391

 
(1,061,391
)
 
1,410,651

Total Albemarle Corporation shareholders’ equity
1,359,465

 

 
1,570,298

 
(1,570,298
)
 
1,359,465

Noncontrolling interests

 

 
129,170

 

 
129,170

Total equity
1,359,465

 

 
1,699,468

 
(1,570,298
)
 
1,488,635

Total liabilities and equity
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103


Condensed Consolidating Statement Of Cash Flows
Three Months Ended March 31, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
46,397

 
(18,121
)
 
26,593

 
(9,078
)
 
45,791

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Acquisition of Rockwood, net of cash acquired
(3,597,083
)
 
159,409

 
1,386,029

 

 
(2,051,645
)
Acquisition of remaining interest in Shanghai Chemetall, net of cash acquired

 

 
(45,550
)
 

 
(45,550
)
Capital expenditures
(19,876
)
 

 
(36,865
)
 

 
(56,741
)
Decrease in restricted cash

 

 
57,550

 

 
57,550

Sales of marketable securities, net
1,557

 

 

 

 
1,557

Proceeds from repayment of advance to joint venture
2,156

 

 

 

 
2,156

Proceeds from intercompany investing related activity

 
891,290

 
82

 
(891,372
)
 

Intercompany investing related payments

 
(1,028,367
)
 
(1,175,700
)
 
2,204,067

 

Net cash (used in) provided by investing activities
(3,613,246
)
 
22,332

 
185,546

 
1,312,695

 
(2,092,673
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(1,325,102
)
 

 
(1,161
)
 

 
(1,326,263
)
Proceeds from borrowings of long-term debt
1,000,000

 

 

 

 
1,000,000

Other borrowings (repayments), net
184,418

 

 
(16,847
)
 

 
167,571

Dividends paid to shareholders
(21,730
)
 

 

 

 
(21,730
)
Intercompany dividends paid

 

 
(9,078
)
 
9,078

 

Proceeds from exercise of stock options
90

 

 

 

 
90

Excess tax benefits realized from stock-based compensation arrangements
23

 

 

 

 
23

Withholding taxes paid on stock-based compensation award distributions
(1,174
)
 

 

 

 
(1,174
)
Debt financing costs
(1,164
)
 

 

 

 
(1,164
)
Proceeds from intercompany financing related activity
1,829,770

 

 
374,297

 
(2,204,067
)
 

Intercompany financing related payments
(28,039
)
 
(82
)
 
(863,251
)
 
891,372

 

Net cash provided by (used in) financing activities
1,637,092

 
(82
)
 
(516,040
)
 
(1,303,617
)
 
(182,647
)
Net effect of foreign exchange on cash and cash equivalents
1,218

 
(2,075
)
 
2,039

 

 
1,182

(Decrease) increase in cash and cash equivalents
(1,928,539
)
 
2,054

 
(301,862
)
 

 
(2,228,347
)
Cash and cash equivalents at end of period
$
2,263

 
$
2,054

 
$
257,104

 
$

 
$
261,421


Condensed Consolidating Statement Of Cash Flows
Three Months Ended March 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
88,476

 
$

 
$
388,763

 
$

 
$
477,239

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
58,984

 

 
90,189

 

 
149,173

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(14,325
)
 

 
(9,342
)
 

 
(23,667
)
Sales of (investments in) marketable securities, net
2,163

 

 
(12
)
 

 
2,151

Net cash used in investing activities
(12,162
)
 

 
(9,354
)
 

 
(21,516
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(101
)
 

 

 

 
(101
)
Other borrowings (repayments), net

 


 
(8,434
)
 

 
(8,434
)
Dividends paid to shareholders
(19,582
)
 

 

 

 
(19,582
)
Repurchases of common stock
(50,000
)
 

 

 

 
(50,000
)
Proceeds from exercise of stock options
1,255

 

 

 

 
1,255

Excess tax benefits realized from stock-based compensation arrangements
586

 

 

 

 
586

Withholding taxes paid on stock-based compensation award distributions
(2,968
)
 

 

 

 
(2,968
)
Debt financing costs
(1,370
)
 

 

 

 
(1,370
)
Net cash used in financing activities
(72,180
)
 

 
(8,434
)
 

 
(80,614
)
Net effect of foreign exchange on cash and cash equivalents

 


 
(239
)
 

 
(239
)
(Decrease) increase in cash and cash equivalents
(25,358
)
 

 
72,162

 

 
46,804

Cash and cash equivalents at end of period
$
63,118

 
$

 
$
460,925

 
$

 
$
524,043


The 4.625% senior notes issued in September 2012 by RSGI (the “Issuer”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Albemarle Corporation (the “Parent Company Guarantor”) and RHI (the “Guarantor Subsidiary,” and together with the Parent Company Guarantor, the “Guarantors”). The guarantees are general senior unsecured obligations of the Guarantors and rank equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantors that are not, by their terms, otherwise expressly subordinated. The note guarantees will be released when the 4.625% senior notes are repaid or otherwise discharged.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among Parent Company Guarantor, Issuer, Guarantor Subsidiary and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantors to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Parent Company Guarantor, Issuer, Guarantor Subsidiary, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.

Condensed Consolidating Statement of Income
Three Months Ended March 31, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
378,172

 
$

 
$

 
$
687,615

 
$
(181,383
)
 
$
884,404

Cost of goods sold
258,124

 

 

 
546,776

 
(178,962
)
 
625,938

Gross profit
120,048

 

 

 
140,839

 
(2,421
)
 
258,466

Selling, general and administrative expenses
40,517

 

 

 
95,248

 

 
135,765

Research and development expenses
13,368

 

 

 
13,124

 

 
26,492

Acquisition and integration related costs
38,880

 

 

 
20,643

 

 
59,523

Intercompany service fee
5,665

 

 

 
(5,665
)
 

 

Operating profit
21,618

 

 

 
17,489

 
(2,421
)
 
36,686

Interest and financing expenses
(26,656
)
 
(10,771
)
 

 
1,681

 

 
(35,746
)
Intergroup interest and financing expenses
(5,914
)
 
9,061

 

 
(3,147
)
 

 

Other income (expenses), net
28,568

 
(50,052
)
 

 
71,441

 

 
49,957

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
17,616

 
(51,762
)
 

 
87,464

 
(2,421
)
 
50,897

Income tax expense (benefit)
10,892

 
(6,928
)
 

 
11,068

 
(892
)
 
14,140

Income (loss) from continuing operations before equity in net income of unconsolidated investments
6,724

 
(44,834
)
 

 
76,396

 
(1,529
)
 
36,757

Equity in net income of unconsolidated investments (net of tax)
2,019

 

 

 
8,373

 

 
10,392

Net income (loss) from continuing operations
8,743

 
(44,834
)
 

 
84,769

 
(1,529
)
 
47,149

Income (loss) from discontinued operations (net of tax)

 

 

 

 

 

Equity in undistributed earnings of subsidiaries
34,372

 
53,732

 
8,898

 
8,898

 
(105,900
)
 

Net income
43,115

 
8,898

 
8,898

 
93,667

 
(107,429
)
 
47,149

Net income attributable to noncontrolling interests

 

 

 
(4,034
)
 

 
(4,034
)
Net income attributable to Albemarle Corporation
$
43,115

 
$
8,898

 
$
8,898

 
$
89,633

 
$
(107,429
)
 
$
43,115



Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended March 31, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
43,115

 
$
8,898

 
$
8,898

 
$
93,667

 
$
(107,429
)
 
$
47,149

Total other comprehensive loss, net of tax
(299,869
)
 
(248,250
)
 
(248,250
)
 
(635,434
)
 
1,131,834

 
(299,969
)
Comprehensive loss
(256,754
)
 
(239,352
)
 
(239,352
)
 
(541,767
)
 
1,024,405

 
(252,820
)
Comprehensive income attributable to noncontrolling interests

 

 

 
(3,934
)
 

 
(3,934
)
Comprehensive loss attributable to Albemarle Corporation
$
(256,754
)
 
$
(239,352
)
 
$
(239,352
)
 
$
(545,701
)
 
$
1,024,405

 
$
(256,754
)

Condensed Consolidating Statement of Income
Three Months Ended March 31, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
376,324

 
$

 
$

 
$
383,831

 
$
(160,312
)
 
$
599,843

Cost of goods sold
261,593

 

 

 
303,361

 
(160,710
)
 
404,244

Gross profit
114,731

 

 

 
80,470

 
398

 
195,599

Selling, general and administrative expenses
55,769

 

 

 
22,335

 

 
78,104

Research and development expenses
14,156

 

 

 
8,416

 

 
22,572

Restructuring and other charges, net
3,000

 

 

 
14,000

 

 
17,000

Intercompany service fee
5,070

 

 

 
(5,070
)
 

 

Operating profit
36,736

 

 

 
40,789

 
398

 
77,923

Interest and financing expenses
(8,798
)
 

 

 
25

 

 
(8,773
)
Other income, net
208

 

 

 
935

 

 
1,143

Income from continuing operations before income taxes and equity in net income of unconsolidated investments
28,146

 

 

 
41,749

 
398

 
70,293

Income tax expense
10,371

 

 

 
2,674

 
145

 
13,190

Income from continuing operations before equity in net income of unconsolidated investments
17,775

 

 

 
39,075

 
253

 
57,103

Equity in net income of unconsolidated investments (net of tax)
1,936

 

 

 
6,965

 

 
8,901

Net income from continuing operations
19,711

 

 

 
46,040

 
253

 
66,004

Loss from discontinued operations (net of tax)
(413
)
 

 

 
(1,356
)
 

 
(1,769
)
Equity in undistributed earnings of subsidiaries
37,285

 

 

 

 
(37,285
)
 

Net income
56,583

 

 

 
44,684

 
(37,032
)
 
64,235

Net income attributable to noncontrolling interests

 

 

 
(7,652
)
 

 
(7,652
)
Net income attributable to Albemarle Corporation
$
56,583

 
$

 
$

 
$
37,032

 
$
(37,032
)
 
$
56,583



Condensed Consolidating Statement of Comprehensive Income
Three Months Ended March 31, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
56,583

 
$

 
$

 
$
44,684

 
$
(37,032
)
 
$
64,235

Total other comprehensive loss, net of tax
(9,318
)
 

 

 
(5,262
)
 
5,045

 
(9,535
)
Comprehensive income
47,265

 

 

 
39,422

 
(31,987
)
 
54,700

Comprehensive income attributable to noncontrolling interests

 

 

 
(7,435
)
 

 
(7,435
)
Comprehensive income attributable to Albemarle Corporation
$
47,265

 
$

 
$

 
$
31,987

 
$
(31,987
)
 
$
47,265


Condensed Consolidating Balance Sheet
March 31, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
2,263

 
$
2,054

 
$

 
$
257,104

 
$

 
$
261,421

Trade accounts receivable, less allowance for doubtful accounts
105,835

 

 

 
521,130

 

 
626,965

Other accounts receivable
12,518

 
23,216

 

 
47,299

 

 
83,033

Intergroup receivable
56,069

 
49

 

 
40,953

 
(97,071
)
 

Inventories
201,563

 

 

 
431,877

 
(13,263
)
 
620,177

Other current assets
88,100

 

 

 
104,692

 
(97,845
)
 
94,947

Total current assets
466,348

 
25,319

 

 
1,403,055

 
(208,179
)
 
1,686,543

Property, plant and equipment, at cost
1,737,949

 

 

 
2,283,684

 

 
4,021,633

Less accumulated depreciation and amortization
1,060,877

 

 

 
343,729

 

 
1,404,606

Net property, plant and equipment
677,072

 

 

 
1,939,955

 

 
2,617,027

Investments
74,362

 
4,891

 

 
573,719

 

 
652,972

Investment in subsidiaries
6,963,998

 
4,735,428

 
6,368,687

 
6,368,690

 
(24,436,803
)
 

Other assets
28,247

 
12,319

 

 
152,245

 
(12,599
)
 
180,212

Goodwill
49,214

 

 

 
2,660,456

 

 
2,709,670

Other intangibles, net of amortization
20,282

 

 

 
1,928,053

 

 
1,948,335

Intergroup receivable

 
3,311,210

 
61

 
1,817,653

 
(5,128,924
)
 

Total assets
$
8,279,523

 
$
8,089,167

 
$
6,368,748

 
$
16,843,826

 
$
(29,786,505
)
 
$
9,794,759

Liabilities and Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
119,879

 
$

 
$

 
$
220,936

 
$

 
$
340,815

Intergroup payable
40,939

 

 
36

 
56,096

 
(97,071
)
 

Accrued expenses
154,992

 
119,221

 

 
279,734

 

 
553,947

Current portion of long-term debt
461,767

 

 

 
10,042

 

 
471,809

Dividends payable
32,261

 

 

 

 

 
32,261

Income taxes payable

 
97,845

 

 
58,404

 
(98,737
)
 
57,512

Total current liabilities
809,838

 
217,066

 
36

 
625,212

 
(195,808
)
 
1,456,344

Long-term debt
2,218,848

 
1,291,442

 

 
31,022

 

 
3,541,312

Postretirement benefits
55,578

 

 

 

 
(280
)
 
55,298

Pension benefits
125,659

 

 

 
325,533

 

 
451,192

Intergroup payable
1,804,370

 
153,002

 
863,757

 
2,307,795

 
(5,128,924
)
 

Other noncurrent liabilities
52,263

 
58,970

 

 
130,738

 

 
241,971

Deferred income taxes
103,584

 

 

 
710,047

 
(12,319
)
 
801,312

Commitments and contingencies
 
 
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
 
 
Common stock
1,122

 

 

 
6,808

 
(6,808
)
 
1,122

Additional paid-in capital
2,049,309

 
6,608,039

 
5,744,307

 
12,117,045

 
(24,469,391
)
 
2,049,309

Accumulated other comprehensive loss
(362,282
)
 
(248,250
)
 
(248,250
)
 
(686,412
)
 
1,182,912

 
(362,282
)
Retained earnings
1,421,234

 
8,898

 
8,898

 
1,138,091

 
(1,155,887
)
 
1,421,234

Total Albemarle Corporation shareholders’ equity
3,109,383

 
6,368,687

 
5,504,955

 
12,575,532

 
(24,449,174
)
 
3,109,383

Noncontrolling interests

 

 

 
137,947

 

 
137,947

Total equity
3,109,383

 
6,368,687

 
5,504,955

 
12,713,479

 
(24,449,174
)
 
3,247,330

Total liabilities and equity
$
8,279,523

 
$
8,089,167

 
$
6,368,748

 
$
16,843,826

 
$
(29,786,505
)
 
$
9,794,759


Condensed Consolidating Balance Sheet
December 31, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,930,802

 
$

 
$

 
$
558,966

 
$

 
$
2,489,768

Trade accounts receivable, less allowance for doubtful accounts
91,849

 

 

 
293,363

 

 
385,212

Other accounts receivable
19,033

 

 

 
30,390

 

 
49,423

Intergroup receivable
74,102

 

 

 
18,097

 
(92,199
)
 

Inventories
201,006

 

 

 
171,543

 
(14,188
)
 
358,361

Other current assets
45,901

 

 

 
25,111

 
(4,926
)
 
66,086

Total current assets
2,362,693

 

 

 
1,097,470

 
(111,313
)
 
3,348,850

Property, plant and equipment, at cost
1,726,690

 

 

 
893,980

 

 
2,620,670

Less accumulated depreciation and amortization
1,047,372

 

 

 
341,430

 

 
1,388,802

Net property, plant and equipment
679,318

 

 

 
552,550

 

 
1,231,868

Investments
73,500

 

 

 
120,542

 

 
194,042

Investment in subsidiaries
1,551,071

 

 

 

 
(1,551,071
)
 

Other assets
35,837

 

 

 
125,119

 

 
160,956

Goodwill
49,212

 

 

 
194,050

 

 
243,262

Other intangibles, net of amortization
20,834

 

 

 
23,291

 

 
44,125

Total assets
$
4,772,465

 
$

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Liabilities and Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
122,479

 
$

 
$

 
$
109,226

 
$

 
$
231,705

Intergroup payable
18,097

 

 

 
74,102

 
(92,199
)
 

Accrued expenses
84,619

 

 

 
81,555

 

 
166,174

Current portion of long-term debt
692,280

 

 

 
18,816

 

 
711,096

Dividends payable
21,458

 

 

 

 

 
21,458

Income taxes payable
1,396

 

 

 
7,944

 
113

 
9,453

Total current liabilities
940,329

 

 

 
291,643

 
(92,086
)
 
1,139,886

Long-term debt
2,214,755

 

 

 
8,280

 

 
2,223,035

Postretirement benefits
56,424

 

 

 

 

 
56,424

Pension benefits
128,238

 

 

 
42,296

 

 
170,534

Other noncurrent liabilities
51,936

 

 

 
35,769

 

 
87,705

Deferred income taxes
21,318

 

 

 
35,566

 

 
56,884

Commitments and contingencies
 
 
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
 
 
Common stock
780

 

 

 
6,808

 
(6,808
)
 
780

Additional paid-in capital
10,447

 

 

 
553,172

 
(553,172
)
 
10,447

Accumulated other comprehensive loss
(62,413
)
 

 

 
(51,073
)
 
51,073

 
(62,413
)
Retained earnings
1,410,651

 

 

 
1,061,391

 
(1,061,391
)
 
1,410,651

Total Albemarle Corporation shareholders’ equity
1,359,465

 

 

 
1,570,298

 
(1,570,298
)
 
1,359,465

Noncontrolling interests

 

 

 
129,170

 

 
129,170

Total equity
1,359,465

 

 

 
1,699,468

 
(1,570,298
)
 
1,488,635

Total liabilities and equity
$
4,772,465

 
$

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103


Condensed Consolidating Statement Of Cash Flows
Three Months Ended March 31, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
1,930,802

 
$

 
$

 
$
558,966

 
$

 
$
2,489,768

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
46,397

 
(18,203
)
 
82

 
26,593

 
(9,078
)
 
45,791

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisition of Rockwood, net of cash acquired
(3,597,083
)
 
159,409

 

 
1,386,029

 

 
(2,051,645
)
Acquisition of remaining interest in Shanghai Chemetall, net of cash acquired

 

 

 
(45,550
)
 

 
(45,550
)
Capital expenditures
(19,876
)
 

 

 
(36,865
)
 

 
(56,741
)
Decrease in restricted cash

 

 

 
57,550

 

 
57,550

Sales of marketable securities, net
1,557

 

 

 

 

 
1,557

Proceeds from repayment of advance to joint venture
2,156

 

 

 

 

 
2,156

Proceeds from intercompany investing related activity

 
891,290

 

 
82

 
(891,372
)
 

Intercompany investing related payments

 
(1,028,367
)
 

 
(1,175,700
)
 
2,204,067

 

Net cash (used in) provided by investing activities
(3,613,246
)
 
22,332

 

 
185,546

 
1,312,695

 
(2,092,673
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(1,325,102
)
 

 

 
(1,161
)
 

 
(1,326,263
)
Proceeds from borrowings of long-term debt
1,000,000

 

 

 

 

 
1,000,000

Other borrowings (repayments), net
184,418

 

 

 
(16,847
)
 

 
167,571

Dividends paid to shareholders
(21,730
)
 

 

 

 

 
(21,730
)
Intercompany dividends paid

 

 

 
(9,078
)
 
9,078

 

Proceeds from exercise of stock options
90

 

 

 

 

 
90

Excess tax benefits realized from stock-based compensation arrangements
23

 

 

 

 

 
23

Withholding taxes paid on stock-based compensation award distributions
(1,174
)
 

 

 

 

 
(1,174
)
Debt financing costs
(1,164
)
 

 

 

 

 
(1,164
)
Proceeds from intercompany financing related activity
1,829,770

 

 

 
374,297

 
(2,204,067
)
 

Intercompany financing related payments
(28,039
)
 

 
(82
)
 
(863,251
)
 
891,372

 

Net cash provided by (used in) financing activities
1,637,092

 

 
(82
)
 
(516,040
)
 
(1,303,617
)
 
(182,647
)
Net effect of foreign exchange on cash and cash equivalents
1,218

 
(2,075
)
 

 
2,039

 

 
1,182

(Decrease) increase in cash and cash equivalents
(1,928,539
)
 
2,054

 

 
(301,862
)
 

 
(2,228,347
)
Cash and cash equivalents at end of period
$
2,263

 
$
2,054

 
$

 
$
257,104

 
$

 
$
261,421


Condensed Consolidating Statement Of Cash Flows
Three Months Ended March 31, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
88,476

 
$

 
$

 
$
388,763

 
$

 
$
477,239

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
58,984

 

 

 
90,189

 

 
149,173

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(14,325
)
 

 

 
(9,342
)
 

 
(23,667
)
Sales of (investments in) marketable securities, net
2,163

 

 

 
(12
)
 

 
2,151

Net cash used in investing activities
(12,162
)
 

 

 
(9,354
)
 

 
(21,516
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(101
)
 

 

 

 

 
(101
)
Other borrowings (repayments), net

 

 

 
(8,434
)
 

 
(8,434
)
Dividends paid to shareholders
(19,582
)
 

 

 

 

 
(19,582
)
Repurchases of common stock
(50,000
)
 

 

 

 

 
(50,000
)
Proceeds from exercise of stock options
1,255

 

 

 

 

 
1,255

Excess tax benefits realized from stock-based compensation arrangements
586

 

 

 

 

 
586

Withholding taxes paid on stock-based compensation award distributions
(2,968
)
 

 

 

 

 
(2,968
)
Debt financing costs
(1,370
)
 

 

 

 

 
(1,370
)
Net cash used in financing activities
(72,180
)
 

 

 
(8,434
)
 

 
(80,614
)
Net effect of foreign exchange on cash and cash equivalents

 

 

 
(239
)
 

 
(239
)
(Decrease) increase in cash and cash equivalents
(25,358
)
 

 

 
72,162

 

 
46,804

Cash and cash equivalents at end of period
$
63,118

 
$

 
$

 
$
460,925

 
$

 
$
524,043